Objective This study examines the electromyography pattern of abdominal trigger points developed after a caesarean section, and the association between clinical response and local anaesthetic injection.
Introduction
Caesarean section (CS) is one of the most common surgeries performed worldwide. Furthermore, the use of the procedure has reached epidemic proportions in emergent countries, especially in Brazil.
1,2 A well-documented longterm complication of CS is chronic pain, which may occur in approximately 1-18% of patients. 3, 4 The majority of abdominal or pelvic chronic pain is described as a disease of the intraabdominal or intrapelvic viscera; however, data in the literature suggest that persistent pain may originate from the abdominal wall, usually secondary to inguinal neuralgia, 5 myofascial trigger points, 6 or even the development of adhesions, 7, 8 especially when related to raised scars. 6 Clinically, the Carnett's sign helps physicians to identify a painful condition originating from the abdominal wall. 9, 10 Carnett's sign is observed if, during a clinical examination, abdominal pain remains the same or increases when the patient is asked to tense the muscles of the abdominal wall. The presence of Carnett's sign increases the likelihood that the abdominal wall is the source of the pain. Some conditions are accompanied by classical signs of neuropathic pain. 11 This makes it easier to diagnose ilioinguinal and iliohypogastric neuralgia; 12 however, many cases involve no typical symptoms or signs of neuralgia, and are attributed to 'myofascial' pain syndrome. In cases such as these the diagnosis and localisation are made via clinical examination, but there is no uniform criterion for this. 13 In addition, abdominal wall trigger points may be associated with visceral causes of pain, including endometriosis. 14, 15 In fact, there is not enough knowledge about the pathophysiology of trigger points in the abdominal wall. Thus, it is almost impossible to distinguish between a true nerve entrapment, a 'myofascial' trigger point in the rectus abdominal muscle, and endometriosis. 16 Overlooking the real cause of the problem may lead to unnecessary surgery, inadequate therapies, or a delay in treatment, especially if the pain does not originate from a recognised nerve injury.
In our experience, women with abdominal trigger points after CS form a very heterogeneous group, and neither clinical history nor physical examination provide sufficient data for a satisfactory prediction of treatment response. 17 Some studies have documented needle electromyography of trigger points in trapezius, 18 masseter and temporal muscles, 19 and ilioinguinal-iliohypogastric nerve entrapment syndrome. 20 Because this method produces an objective report, we examined the electromyography pattern of 'myofascial' abdominal trigger points secondary to CS, and sought to verify the association of these findings with the clinical response of patients to local anaesthetic injection.
Methods

Design and study population
Twenty-nine women with chronic pain after caesarean section, originating from the abdominal wall and associated with clinically detected 'myofascial' abdominal trigger points, without allodynia or typical symptoms or signs of neuralgia, were consecutively recruited between October 2011 and November 2013. All patients presented positive for Carnett's sign. Typical neuralgia was considered present when a patient presented with spontaneous episodic intermittent pain of a relatively short duration; the pain was often described as shooting, stabbing, or electric-like, and presented with dysaesthesia and/or paraesthesia, including itching, numbness, tingling, and pins-and-needles sensations.
The participants were recruited at the Centre for Gynaecological Endoscopy and Pelvic Pain at the Clinical Hospital of the Ribeirão Preto Medical School, University of Sao Paulo, which is a referral centre within a teaching tertiary hospital. Figure 1 represents the location of trigger points. A trigger point was defined as a spastic area of approximately 1-2 cm 2 inside the muscular tissue. When a patient presented with more than one trigger point, we choose the one that triggered the pain most frequently experienced by the woman in her daily life.
The research protocol included clinical evaluation by a consultant gynaecologist, pelvic and abdominal wall ultrasonography (to rule out endometriomas and/or hernias), pain intensity evaluation using the visual analogue scale (VAS) and the McGill pain questionnaire, 21 regarding the average abdominal pain experienced in the last month, as well as the measurement of anxiety and depression symptoms using the Hospital Anxiety and Depression Scale (HADS). Women with a body mass index (BMI) >30 kg/m 2 were ineligible (n = 4). Women were not eligible if they had a previous and known diagnosis of concomitant endometriosis (diagnosed via visual inspection of the pelvis during laparoscopy, histology, or suggested because of severe dysmenorrhoea), 22 painful bladder syndrome (pain when the bladder starts to fill, urinary frequency, nocturia, and urgency, or cystoscopy evidencing glomerulations or Hunner's ulcers), 23 or irritable bowel syndrome (Roma-III criteria). 24 The study was approved by the local ethics committee, and all subjects voluntarily provided written informed consent under protocol number 13137/2009. The study has also been registered at the Brazilian Clinical Trials Registry (REBEC) under RBR-42c6gz (www.ensaiosclinicos.gov.br/ rg/RBR-42c6gz/).
Electromyography
The needle electromyography examinations were performed in the Laboratory of Clinical Neurophysiology at the same hospital by a single evaluator who was blinded to all of the clinical information. After cleaning the skin with alcohol, the trigger point and corresponding contralateral painless point were marked by an '9' with a dermographic pen. A disposable monopolar needle electrode (37 mm 9 26 G) was used (Anvisa ref. 10263610043; Chalgren Enterprises, Gilroy, CA, USA), and a disc-shaped reference electrode (1 cm in diameter) was placed 3 cm from the needle electrode. The needle electrode was inserted into the trigger point and the contralateral painless point that was marked by the first evaluator. Electromyography included the following steps: (1) insertion activity and the presence of abnormal spontaneous discharges (fibrillations, acute positive waves, fasciculation, and rapid repetitive discharges) were monitored; (2) in the presence of a mild-to-moderate contraction, the characteristics of the motor unit action potentials were determined; and (3) the recruitment and the interference pattern were studied. To evaluate the insertion activity and the presence of spontaneous activity, the electromyography machine set-up included a 100-ms analysis period, a gain of 50-200 lV, and a filter of 10 Hz to 10 kHz. For evaluation of the motor unit action potential, the analysis time was 50 or 100 ms with a gain of 200 lV to 2 mV, and a filter of 10 Hz to 10 kHz. In recruitment and interference pattern evaluations, a 100-ms analysis time was used with a gain of 0.5-1.0 mV and a filter of 2 Hz to 10 kHz. The examination was conducted using a Nihon Kohden â Neuropack 4-channel device (Nihon Kohden Corporation, Tokyo, Japan). The volunteers remained in the dorsal decubitus position throughout the examination. Only one woman refused the needle electromyography procedure because of intense fear; she was therefore not included in the study. The abnormal patterns included signals of acute denervation/reinnervation and chronic denervation.
25,26
Algometry
The pain threshold, i.e. the minimal pressure (force) that induced pain, was assessed using an Instrutherm DD-500 pressure algometer with digital traction and compression, with a measurement capacity of 5 kg (digital dynamometer, model DD500; Instrutherm Instrumentos de Medic ßão Ltda, São Paulo, SP, Brazil). Three consecutive measurements were taken (with 20-min intervals between them), and the mean was used in the analysis. The algometry was measured over the trigger point and over the contralateral region without pain.
Treatment
One week after electromyography, patients were submitted to a treatment protocol consisting of an injection of 2 ml of 1% lidocaine with a 22-gauge, 0.70 mm 9 0.25 mm, needle directly perpendicular to the trigger point. 27 The protocol was repeated once a week for four consecutive weeks. Patients were submitted to two post-treatment evaluations: at 1 week and at 3 months after the last injection. Post-treatment evaluation included VAS, HADS, and algometry.
Outcomes
Primary outcomes included the prevalence of electromyography abnormalities and VAS measurement before and after treatment (http://bvsms.saude.gov.br/bvs/saudelegis/sa s/2012/prt1083_02_10_2012.html). Diagnostic laparoscopy was performed in all patients without clinical response at the 3-month evaluation.
Statistical analysis
The statistical analysis was performed with JMP 12 for Mac (SAS Institute, Cary, NC, USA). First, we described the prevalence of the electromyography abnormalities. We then divided the participants into two subgroups: with and without abnormalities. The Wilcoxon/Kruskal-Wallis test was used to analyse the differences between subgroups. To analyse paired VAS measurements before and after treatment, we used the Wilcoxon signed rank test. The Fisher exact test was used to evaluate differences among subgroups, considering significant pain relief as a binary variable. We considered a clinically relevant reduction in pain to be significant pain relief when a subject presented with a VAS reduction of at least 50%, or related a significant impact on her daily life activities measured by subjective impression. Quantitative variables were expressed as the mean and standard deviation or by the median and range.
Results
The characterization of participants is presented in Table 1 . Fifteen patients (51.7%) presented electromyography findings indicative of denervation and/or reinnervation, and 14 (48.3%) had no abnormalities. Patients with and without electromyographic abnormalities had comparable baseline characteristics. Among patients with electromyographic abnormalities, nine had signs of acute denervation with reinnervation, two had signs of acute denervation, and four had signs of chronic denervation with reinnervation. The individual results of the electromyography are presented in Table S1 .
The overall rates of response to treatment were 65.5% (n = 19/29) at 1 week and 62.1% (n = 18/29) at 3 months after treatment. Ninety-three percent (n = 14/15) of patients with electromyographic abnormalities showed immediate improvement after the treatment, versus only 35.7% (n = 5/14) of those with normal electromyography (P = 0.0017). Those with electromyographic signs of denervation and/or reinnervation presented with a significant reduction of VAS measurements after treatment: 62.5 AE 15.7 mm versus 35.7 AE 22.5 mm (P = 0.0008), respectively. Those without electromyographic abnormalities showed less improvement: 79.0 AE 19.9 mm versus 46.1 AE 26.6 mm (P = 0.00374), respectively.
After 3 months of follow-up, two women in the group with electromyographic abnormalities presented with clinically significant pain. Both underwent laparoscopy. No abnormal findings were identified during the procedure in either subject. All patients made use of tricyclic antidepressants, and they were symptom-free after more than a year of follow-up. Among patients with normal electromyography, five patients (35.7%, n = 5/14) with immediate clinical response were without pain after 3 months. The remaining patients (64.3%, n = 9/14) had no improvement in their pain symptoms. Two underwent laparoscopy, and there was evidence of peritoneal adhesions in 55.6% (n = 5/9) of them.
Tolerable pain at the time of needle insertion was a common complaint. Four women (13.8%) experienced a haematoma after the examination that spontaneously resolved.
Discussion
Main findings
Based on electromyography, we concluded that half of the trigger points attributed to myofascial syndrome were actually neuropathies, with the presence of typical changes in neuronal injury and with a favourable response to local anaesthetic and tricyclic antidepressant medications, known to be effective in the treatment of neuropathic pain. 28 
Strengths and limitations
The careful selection of patients, the uniformity of the clinical data of the sample, and the statistical power guarantees that the information is representative and can be generalised for this population.
Nevertheless, our evidence is not enough to recommend the use of electromyography in clinical practice. As this examination causes some discomfort to the patient, and can be associated with minor complications such as a small haematoma, less invasive methods are desirable for detecting electrical modifications at trigger points.
Interpretation
Although electromyography makes an electrical record of muscle activity, the presence of alterations suggestive of neuronal damage suggests that adjacent afferent fibres may also be damaged, contributing to the origin and maintenance of pain. Furthermore, neural inflammation and axonal degeneration may modify the electrical behaviour of adjacent uninterrupted/conducting fibres, 29 and increase spontaneous electrical activity and input to the central nervous system, which may lead to the development of chronic pain. 30 With regards to the use of local anaesthetic, it is known that lidocaine blocks the sodium channels of afferent fibres, reduces the electrical activity of the afferent neuron, 31 and consequently interrupts the cycle of pain in a short time. The long-term effects are not always positive, however, 27, 32 despite some authors relating favourable long-term results after anaesthetic injection. 33 This may be explained by the reduction of inflammation for TRPV1 and the activation of TRPA1. 34 The absence of electromyography alteration does not exclude the possibility of neuronal impairment, particularly of small-diameter A-delta and C-fibre sensory nerves, as the method only accesses the components of the motor unit. 35 There is also evidence that the sensitisation of these fibres may culminate in musculoskeletal symptoms. 36 This may explain the existence of women with trigger points not associated with electromyographic changes that improve with the injection of local anaesthetics. Further studies would be required to determine the significance of needling or the placebo effect. 32 Interestingly, within the group of women with no change in electromyography, half had peritoneal adhesions, and the other half remained without a specific diagnosis, even after further investigation that included magnetic resonance imaging. The latter were the patients with the highest scores for symptoms of anxiety and depression, which makes us think that some trigger points may represent a somatic manifestation of psychological dysfunction or reaction. This association has already been described, 37 and the presence of somatization symptoms negatively predicts the response to treatment by local injection. 38 Unfortunately, the design of our study did not allow for more robust considerations regarding this potential association.
Conclusion
Trigger points developed after CS seem to originate from neuropathies, even in the absence of typical clinical symptoms and signs of neuralgia. Most patients experience significant pain relief after anaesthetic injection. Laparoscopy may be a useful tool to investigate the origin of abdominal wall trigger points when clinical treatment is ineffective, and psychosomatic disorder is another potential cause of this somatic symptom, reinforcing the need for a multidisciplinary approach.
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